EPIDEMIOLOGICAL SURVEILLANCE AND POLICY OF SPECIFIC PROPHYLAXIS OF INVASIVE PNEUMOCOCCAL INFECTIONS IN RUSSIA


Cite item

Full Text

Abstract

Literature data on contemporary state of specific prophylaxis of invasive pneumococcal infections in Russia and abroad are summarized in the review. Main advantages and disadvantages of existing polysaccharide and conjugated vaccines are discussed. Main routes for epidemiologic surveillance for invasive pneumococcal infections which will promote improvement of analytic, diagnostic and management activities of specialists from Federal Service on Surveillance for Protection of Consumers Rights and Human Welfare are proposed. Recommendations on assessment of invasive pneumococcal disease burden as well as on policy of its prevention are provided.

Full Text

ЭПИДЕМИОЛОГИЧЕСКИЙ НАДЗОР И ТАКТИКА СПЕЦИФИЧЕСКОЙ ПРОФИЛАКТИКИ ИНВАЗИВНЫХ ПНЕВМОКОККОВЫХ ИНФЕКЦИЙ В РОССИИ
×

About the authors

L. A Ryapis

Sechenov Moscow Medical Academy, Russia

N. I Briko

Sechenov Moscow Medical Academy, Russia

References

  1. Баранов А.А., Горелов А.В., Задорожная В.И. и др. Современное состояние проблемы Hib- инфекции в Беларуси, Казахстане, России и Украине. Заявление группы экспертов в области вакцинопрофилактики. Вопр. совр. педиатр. 2006, 5 (2): 6-11.
  2. Брико Н.И. Стратегия и тактика эпидемиологического надзора за стрептококковой инфекцией. Журн. микробиол. 2009, 2: 103-107.
  3. Козлов Р.С. Пневмококки: прошлое, настоящее и будущее. Смоленск, 2005.
  4. Мартынова А.В. Эпидемиологические аспекты пневмококковых инфекций и молекулярно-генетическая характеристика Streptococcus pneumoniae. Автореф. дисс. д-ра мед. наук. Санкт-Петербург, 2008.
  5. Методические указания по определению чувствительности микроорганизмов к антибактериальным препаратам. МУК 4.2.1890-04.
  6. Пахомов Д.В., Костинов М.П., Поддубиков А.В. и др. Иммунологический эффект вакцинации против пневмококковой инфекции у ВИЧ-инфицированных детей. Журн. микро- биол. 2009, 2: 48-52.
  7. Таточенко В.К. Острые пневмонии у детей. Чебоксары, 1994.
  8. Albanese B.A., Rocche J.C., Pass M. et al. Geographic, demographic and seasonal differences in penicillin-resistant Streptococcus pneumoniae in Baltimore. Clin. Infect. Dis. 2002, 34: 15-21.
  9. Bogaert D., Engelen M., Timmers-Reker A.J.M. et al. Pneumococcal carriage in children in the Netherlands: a molecular epidemiology study. J. Clin. Microbiol. 2001, 39 (9): 3316-3320.
  10. Calbo E., Diaz A., Canadell E. et al. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin. Microbiol. Infect. 2006, 12 (9): 867-972.
  11. Casado-Flores J., Rodrigo C., Aristegui J. et al. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 2008, 27 (11): 1020-1022.
  12. Chiou C.C., McEllistrem. Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotypes 23F and 19F in Taiwan which differ from international epidemic clones. J. Clin. Microbiol. 2001, 39 (3): 1144-1147.
  13. Doern G., Brueggeann A.B., Huynb H. et al. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-1998. Emerg. Infect. Dis. 1999, 5: 757-765.
  14. Doern G., Brueggeann A.B., Bloker M et al. Clonal relationships among high-level penicillinresistant Streptococcus pneumoniae in the United States. Clin. Infect. Dis. 1998, 27: 757-761.
  15. Hausdorff W.P., Bryant J., Kloek C. et al. The construction of specific pneumococcal serogroups to different disease manifestations: implication for conjugate vaccine formulation and use, part II. Ibid. 2000, 30: 122-140.
  16. Hausdorff W.P., Siber G., Paradiso P.R. Geographical differences in invasive pneumococcal diseases rates and serotype frequency in young children. Lancet. 2001, 24 (9260): 950-951.
  17. Huss A., Scott P., Stucr A.E et al. Efficacy of pneumococcal vaccination in adults: metaanalysis. CMFJ. 2009, 80 (1): 1503.
  18. Inostroza J., Vinet A.M., Retamal G. et al. Influence of patient age on Streptococcus pneumoniae serotypes causing invasive diseases. Clin. Diagn. Lab. Immunol. 2001, 8 (3): 556-55.
  19. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction — eight states, 1998 — 2005. MMWR. 2008, 57 (06): 144-148.
  20. Ip M., Lyon D., Yang R.W.H. et al. Introduction of new clones of penicillin-no susceptible Streptococcus pneumoniae in Hong Kong. J. Clin. Microbiol. 2002, 40 (4): 1522-1525.
  21. Keaw M.H., Clarke S., Edwards G.F. et al. Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol. Infect. 2000, 125: 561-572.
  22. Nooks K., Epode R.G., Gungabisson U. et al. Pneumococcal polysaccharide vaccine uptake in England, 1989-2003, prior to the introduction of a vaccination program for older adults. J. Publ. Health. 2006, 28: 242-247.
  23. Porat N., Trifler R., Dagan R. Persistence of two invasive Streptococcus pneumoniae clones 1 and in comparison to that of multiple clones of serotypes 6B and 23 famong children in Southern Israel. J. Clin. Microbiol. 2001, 39 (5): 1827-1832.
  24. Preventing pneumococcal disease among infants and young children. Recommendations of the advisory committee on immunization practices (ACIP). MMWR. 2000, 49: RR-9.
  25. Recommended adult immunization schedule — United States, October 2006 — September 2007. Ibid. 2006, 55: Q1-4.
  26. Syrogiannopouious G.A., Bogart D., Grivea N.G. et al. Molecular epidemiology of penicillinsusceptible, multidrug-resistant serotype 6B pneumococci isolated from children in Greece. J. Clin Microbiol. 2001, 39 (2): 581-585.
  27. Tsai C.J., Griffin M. R., Nuorti P., Grijalva C.G. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin. Infect. Dis. 2008, 46: 1644-1672.
  28. Whitney C.G., Farley M.M., Hadler J. et al. Decline in invasive pneumococcal disease after introduction of protein-polysaccharide conjugate vaccine. New Engl. J. Mtd. 2003, 348: 1737-1746.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Ryapis L.A., Briko N.I.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies